Dibra D - Search Results

1

p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator.

McDaniel JM, Morrissey RL, Dibra D, Patel LR, Xiong S, Zhang Y, Chau GP, Su X, Qi Y, El-Naggar AK, Lozano G. McDaniel JM, et al. Among authors: dibra d. Cancer Res Commun. 2024 Aug 1;4(8):1991-2007. doi: 10.1158/2767-9764.CRC-24-0128. Cancer Res Commun. 2024. PMID: 38994678 Free PMC article.

2

Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo.

Dibra D, Xiong S, Moyer SM, El-Naggar AK, Qi Y, Su X, Kong EK, Korkut A, Lozano G. Dibra D, et al. Sci Adv. 2024 Feb 16;10(7):eadk1835. doi: 10.1126/sciadv.adk1835. Epub 2024 Feb 14. Sci Adv. 2024. PMID: 38354236 Free PMC article.

3

p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis.

Dibra D, Gagea M, Qi Y, Chau GP, Su X, Lozano G. Dibra D, et al. Cancer Res Commun. 2023 Dec 29;3(12):2640-2652. doi: 10.1158/2767-9764.CRC-23-0218. Cancer Res Commun. 2023. PMID: 38047594 Free PMC article.

4

Triple-negative breast tumors are dependent on mutant p53 for growth and survival.

Dibra D, Moyer SM, El-Naggar AK, Qi Y, Su X, Lozano G. Dibra D, et al. Proc Natl Acad Sci U S A. 2023 Aug 22;120(34):e2308807120. doi: 10.1073/pnas.2308807120. Epub 2023 Aug 14. Proc Natl Acad Sci U S A. 2023. PMID: 37579145 Free PMC article.

5

A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53.

Dibra D, Xia X, Gagea M, Lozano G, Li S. Dibra D, et al. PLoS One. 2018 Mar 1;13(3):e0193485. doi: 10.1371/journal.pone.0193485. eCollection 2018. PLoS One. 2018. PMID: 29494633 Free PMC article.

6

IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin.

Dibra D, Mitra A, Newman M, Xia X, Keenan C, Cutrera JJ, Mathis JM, Wang XJ, Myers J, Li S. Dibra D, et al. Oncotarget. 2016 Nov 22;7(47):77138-77151. doi: 10.18632/oncotarget.12581. Oncotarget. 2016. PMID: 27738312 Free PMC article.

7

Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo.

Dibra D, Mitra A, Newman M, Xia X, Cutrera JJ, Gagea M, Kleinerman ES, Lozano G, Li S. Dibra D, et al. Clin Cancer Res. 2016 Aug 1;22(15):3876-83. doi: 10.1158/1078-0432.CCR-15-2052. Epub 2016 Mar 15. Clin Cancer Res. 2016. PMID: 26979394 Free PMC article.

8

Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice.

Dibra D, Xia X, Mitra A, Cutrera JJ, Lozano G, Li S. Dibra D, et al. Hepatology. 2016 Mar;63(3):1000-12. doi: 10.1002/hep.28379. Epub 2016 Jan 21. Hepatology. 2016. PMID: 26637970 Free PMC article.

9

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Yan J, Kong LY, Hu J, Gabrusiewicz K, Dibra D, Xia X, Heimberger AB, Li S. Yan J, et al. Among authors: dibra d. J Natl Cancer Inst. 2015 May 13;107(8):djv137. doi: 10.1093/jnci/djv137. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 25971300 Free PMC article.

10

Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship.

Dibra D, Mishra L, Li S. Dibra D, et al. Biochim Biophys Acta. 2014 Aug;1846(1):152-60. doi: 10.1016/j.bbcan.2014.05.001. Epub 2014 May 9. Biochim Biophys Acta. 2014. PMID: 24821201 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters